Literature DB >> 589414

Labetalol and urinary catecholamines.

D Harris, D A Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 589414      PMCID： PMC1633300          DOI： 10.1136/bmj.2.6103.1673-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.

Authors:  H J Kornerup; E B Pedersen; N J Christensen; A Pedersen; G Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

2.  Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.

Authors:  T Rosenthal; B Rabinowitz; H Boichis; E Elazar; A Brauner; H N Neufeld
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.

Authors:  P M Bouloux; R M Featherstone; V Clement-Jones; L H Rees; J E Goligher
Journal:  J R Soc Med       Date:  1985-07       Impact factor: 5.344

4.  Labetalol and urinary catecholamines.

Authors:  R Kolloch; L Miano; V De Quattro
Journal:  Br Med J       Date:  1979-01-27

5.  Effects of chronic alpha and beta adrenoceptor blockade with labetalol on plasma catecholamines and renal function in hypertension.

Authors:  G Keusch; P Weidmann; W H Ziegler; R de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-01-02

6.  Effect of labetalol on the uptake of [3H]-(-)-noradrenaline into the isolated vas deferens of the rat.

Authors:  G M Drew; A Hilditch; G P Levy
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

Review 7.  Pharmacology of combined alpha-beta-blockade. I.

Authors:  W J Louis; J J McNeil; O H Drummer
Journal:  Drugs       Date:  1984       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.